Rainmed Medical Limited
Rainmed Medical Limited 2297.HK Peers
See (2297.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2297.HK | $0.16 | N/A | 191.52M | -1.49 | -$0.11 | N/A |
| 2252.HK | $15.86 | +0.38% | 15.85B | -22.34 | -$0.71 | N/A |
| 0853.HK | $6.61 | -0.15% | 12.23B | -6.96 | -$0.95 | N/A |
| 1302.HK | $1.57 | -0.64% | 6.91B | 26.17 | $0.06 | N/A |
| 1789.HK | $5.67 | +1.25% | 6.33B | 21.81 | $0.26 | +0.79% |
| 6606.HK | $14.14 | N/A | 6.32B | 58.92 | $0.24 | N/A |
| 2190.HK | $19.86 | +1.33% | 6.20B | 60.18 | $0.33 | N/A |
| 2172.HK | $10.48 | +1.16% | 6.13B | 21.83 | $0.48 | +1.81% |
| 1858.HK | $10.22 | +7.47% | 6.07B | 28.39 | $0.36 | +4.78% |
| 1763.HK | $12.44 | +7.99% | 3.95B | 9.01 | $1.38 | +5.92% |
Stock Comparison
2297.HK vs 2252.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2252.HK has a market cap of 15.85B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2252.HK trades at $15.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2252.HK's P/E ratio is -22.34. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2252.HK's ROE of -2.32%. Regarding short-term risk, 2297.HK is less volatile compared to 2252.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 0853.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 0853.HK has a market cap of 12.23B. Regarding current trading prices, 2297.HK is priced at $0.16, while 0853.HK trades at $6.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 0853.HK's P/E ratio is -6.96. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 0853.HK's ROE of -0.33%. Regarding short-term risk, 2297.HK is less volatile compared to 0853.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1302.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1302.HK has a market cap of 6.91B. Regarding current trading prices, 2297.HK is priced at $0.16, while 1302.HK trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1302.HK's P/E ratio is 26.17. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1302.HK's ROE of +0.06%. Regarding short-term risk, 2297.HK is less volatile compared to 1302.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1789.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1789.HK has a market cap of 6.33B. Regarding current trading prices, 2297.HK is priced at $0.16, while 1789.HK trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1789.HK's P/E ratio is 21.81. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1789.HK's ROE of +0.11%. Regarding short-term risk, 2297.HK is less volatile compared to 1789.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 6606.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 6606.HK has a market cap of 6.32B. Regarding current trading prices, 2297.HK is priced at $0.16, while 6606.HK trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 6606.HK's P/E ratio is 58.92. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 6606.HK's ROE of -0.04%. Regarding short-term risk, 2297.HK is less volatile compared to 6606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2190.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2190.HK has a market cap of 6.20B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2190.HK trades at $19.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2190.HK's P/E ratio is 60.18. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2190.HK's ROE of +0.03%. Regarding short-term risk, 2297.HK is less volatile compared to 2190.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2172.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2172.HK has a market cap of 6.13B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2172.HK trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2172.HK's P/E ratio is 21.83. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2172.HK's ROE of +0.15%. Regarding short-term risk, 2297.HK is less volatile compared to 2172.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1858.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1858.HK has a market cap of 6.07B. Regarding current trading prices, 2297.HK is priced at $0.16, while 1858.HK trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1858.HK's P/E ratio is 28.39. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1858.HK's ROE of +0.04%. Regarding short-term risk, 2297.HK is less volatile compared to 1858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1763.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1763.HK has a market cap of 3.95B. Regarding current trading prices, 2297.HK is priced at $0.16, while 1763.HK trades at $12.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1763.HK's P/E ratio is 9.01. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1763.HK's ROE of +0.08%. Regarding short-term risk, 2297.HK is less volatile compared to 1763.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 9996.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 9996.HK has a market cap of 3.59B. Regarding current trading prices, 2297.HK is priced at $0.16, while 9996.HK trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 9996.HK's P/E ratio is -14.59. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 2297.HK is less volatile compared to 9996.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2235.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2235.HK has a market cap of 2.59B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2235.HK trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2235.HK's P/E ratio is -38.50. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2235.HK's ROE of -0.03%. Regarding short-term risk, 2297.HK is less volatile compared to 2235.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2500.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2500.HK has a market cap of 2.46B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2500.HK trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2500.HK's P/E ratio is -3.19. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2500.HK's ROE of -0.23%. Regarding short-term risk, 2297.HK is less volatile compared to 2500.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 6669.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 6669.HK has a market cap of 2.34B. Regarding current trading prices, 2297.HK is priced at $0.16, while 6669.HK trades at $7.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 6669.HK's P/E ratio is 43.39. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 6669.HK's ROE of +0.04%. Regarding short-term risk, 2297.HK is less volatile compared to 6669.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2160.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2160.HK has a market cap of 1.95B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2160.HK trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2160.HK's P/E ratio is -40.50. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2160.HK's ROE of -0.02%. Regarding short-term risk, 2297.HK is less volatile compared to 2160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1696.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1696.HK has a market cap of 1.85B. Regarding current trading prices, 2297.HK is priced at $0.16, while 1696.HK trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1696.HK's P/E ratio is 9.40. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1696.HK's ROE of +0.05%. Regarding short-term risk, 2297.HK is less volatile compared to 1696.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 6609.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 6609.HK has a market cap of 1.09B. Regarding current trading prices, 2297.HK is priced at $0.16, while 6609.HK trades at $27.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 6609.HK's P/E ratio is -71.67. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 6609.HK's ROE of -0.01%. Regarding short-term risk, 2297.HK is less volatile compared to 6609.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2216.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2216.HK has a market cap of 1.08B. Regarding current trading prices, 2297.HK is priced at $0.16, while 2216.HK trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2216.HK's P/E ratio is -8.87. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 2297.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2170.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2170.HK has a market cap of 793.23M. Regarding current trading prices, 2297.HK is priced at $0.16, while 2170.HK trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2170.HK's P/E ratio is -2.99. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2170.HK's ROE of -0.20%. Regarding short-term risk, 2297.HK is more volatile compared to 2170.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 6118.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 6118.HK has a market cap of 374.18M. Regarding current trading prices, 2297.HK is priced at $0.16, while 6118.HK trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 6118.HK's P/E ratio is 24.33. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 6118.HK's ROE of +0.02%. Regarding short-term risk, 2297.HK is less volatile compared to 6118.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 1612.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 1612.HK has a market cap of 263.77M. Regarding current trading prices, 2297.HK is priced at $0.16, while 1612.HK trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 1612.HK's P/E ratio is 3.73. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 1612.HK's ROE of +0.12%. Regarding short-term risk, 2297.HK is more volatile compared to 1612.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2297.HK.
2297.HK vs 2393.HK Comparison
2297.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2297.HK stands at 191.52M. In comparison, 2393.HK has a market cap of 186.53M. Regarding current trading prices, 2297.HK is priced at $0.16, while 2393.HK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2297.HK currently has a P/E ratio of -1.49, whereas 2393.HK's P/E ratio is 0.19. In terms of profitability, 2297.HK's ROE is -0.26%, compared to 2393.HK's ROE of +1.71%. Regarding short-term risk, 2297.HK is less volatile compared to 2393.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2297.HK.